Exforge® Receives US Regulatory Approval As A New And Highly Effective Treatment Option For Patients With High Blood Pressure
Thu, 28 Dec 2006 08:00 AM EST
... Novartis announced today the US regulatory approval of Exforge as a new treatment option for patients with high blood pressure. Exforge combines in one tablet the two most commonly prescribed hypertension medicines in their categories - Diovan® (valsartan) and Norvasc®# (amlodipine besylate). [click link for full article] ...
Related Topics
- Hypertension
- Low Blood Pressure
- Blood Pressure
- High Cholesterol
- High Blood Pressure and Kidney Disease
- Blood Pressure, High
- Hypertension/High Blood Pressure
- High blood pressure (hypertension)
- Medications
- Olmesartan
- Medication
- Laboratory Tests
- Blood Cells
- Legal Issues
- Hydrocephalus - Normal Pressure
- Normal Pressure Hydrocephalus
- Blood/Blood Transfusion
- Blood Transfusion
- Platelet Count
- FSH

Not Signed In -


